Allied Corp. Advances Psilocybin Product Psilonex™ RX and Initiates Manufacturing Process
Allied Corp. (ALID) has a new approach for treating depression, anxiety and PTSD.
The Kelowna-based company developed a proprietary formulation called Psilonex RX that combines psilocybin extract with functional mushroom extracts and a blend of vitamins.
Allied Corp. aims to treat patients by prescribing a dose of Psilonex RX followed by a daily dose of its CBD product, Psilonex Daily.
The company just began manufacturing Psilonex RX under an agreement with HAVN Life Sciences (HAVN).